BURBANK — The Screaming O was named Sexual Enhancement Company of the Year in the 2016 StorErotica Awards, held last week at the ANME Founders Show in Burbank, Calif. The award was for Dynamo Delay, described by a Screaming O spokesperson as “the only FDA-compliant male genital desensitizer spray to feature a potent 13 percent Lidocaine USP with a higher concentration and better value.”
Within six months of its debut, Dynamo Delay hit two milestones: a monthly sales record of more than 5000 units and a No. 1 position at Adam & Eve’s Male Sexual Enhancers shop."
“The delay spray continues to set new precedents within the top-selling product category and is now backed by the recognition of this year’s Sexual Enhancement Company of the Year award,” a spokesperson said.
Dynamo Delay, according to a Screaming O representative, “is an over-the-counter human drug product made in the USA with an FDA-approved indication to treat premature ejaculation and slow the onset of orgasm. Using active ingredient Lidocaine, Dynamo Delay provides a topical numbing sensation with a higher concentration that requires less product to provide the same effects. Each bottle of Dynamo Delay contains 50 percent more product with twice the number of sprays at half the cost per spray than the competition, all while delivering better margins.”
Conde Aumann, account executive for The Screaming O, said, “Dynamo Delay is fast-acting and clinically tested to provide safe and effective results with a formula made in the USA according to the FDA’s strict drug protocols. And few others in the category can say the same. The Screaming O team set out to innovate and breathe life into the male genital desensitizer category and created Dynamo Delay to bring a smart alternative to market. It’s an honor to have been recognized for our hard work and success with Dynamo Delay, and we’d like to thank StorErotica and everyone who voted for us in this important awards category.”
For more information on The Screaming O, visit their official website or follow them on Twitter.
